Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Bile Duct Stones—Avoiding the Avoidable
Authors:
- Stefan ChiriacSCStefan Chiriac
- Catalin SfartiCSCatalin Sfarti
- Horia MineaHMHoria Minea
- Sebastian ZenoviaSZSebastian Zenovia
- Irina GirleanuIrina Girleanu
- Laura HuibanLHLaura Huiban
- Cristina MuzicaCristina Muzica
- Adrian RotaruARAdrian Rotaru
- Remus StafieRSRemus Stafie
- Robert NastasaRNRobert Nastasa
- Ermina StratinaESErmina Stratina
- Bogdan Mihnea CiuntuBCBogdan Mihnea Ciuntu
Open Access
- 1 January 2026
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 14 (1) , 91
Abstract
Background: Endoscopic retrograde cholangiopancreatography (ERCP) is the primary treatment option for choledocholithiasis. However, this procedure carries an inherent non-negligible risk of complications, requiring precise indications and careful patient selection. Endoscopic ultrasonography (EUS) can verify the presence of bile duct stones prior to ERCP. The current ESGE recommendations permit ERCP in high-risk patients without confirmation; however, several individuals undergo ERCP without evident advantage, indicating a necessity for enhanced stratification. Objectives: We aim to evaluate the rate of EUS-validated choledocholithiasis in patients with suspected common bile duct (CBD) stones and to determine the predictors of residual stones. A secondary objective was to create and internally validate a streamlined scoring system to enhance risk assessment in ESGE high-risk patients. Methods: We conducted a retrospective analysis of patients who had endoscopic ultrasound for suspected choledocholithiasis from January 2023 to December 2024 at a tertiary center. Multivariate logistic regression determined independent predictors of retained calculi. A simplified score was derived from model coefficients and internally validated. Results: Among 438 examined patients, 186 were included and 87 had choledocholithiasis confirmed via EUS. ERCP was conducted in 81 patients and postponed for 6 patients due to contraindications. According to the ESGE criteria, 10 patients (5.4%) were classified as low risk, 92 (49.5%) as intermediate risk, and 84 (45.2%) as high risk for choledocholithiasis. For high-risk individuals, EUS identified stones in 45 (53.5%), while 39 (46.4%) experienced spontaneous clearance. Acute pancreatitis (aOR 0.075), cholangitis (aOR 6.939), and EUS CBD diameter (aOR 1.220 per mm) were independent predictors of stones. The resultant three-component score (−2 to +4 points) demonstrated effective discrimination (AUROC 0.788). A criterion of ≥2 resulted in 85.7% sensitivity and 59.0% specificity. Conclusions: Almost fifty percent of ESGE high-risk patients were not found to have CBD stones during EUS. Integrating EUS data with a straightforward predictive score may enhance risk classification and avert superfluous ERCP procedures.Keywords
This publication has 24 references indexed in Scilit:
- Suspected common bile duct stones: Which test is best?Surgical Endoscopy, 2025
- The use of endoscopic ultrasound in tandem with endoscopic retrograde cholangiopancreatography in the 2019 American Society for Gastrointestinal Endoscopy guideline for patients at high risk of choledocholithiasis can help to avoid diagnostic endoscopic retrograde cholangiopancreatography in individuals without ascending cholangitisDEN Open, 2025
- Predictive factors of spontaneous common bile duct clearance and unnecessary ERCP in patients with choledocholithiasisClinics and Research in Hepatology and Gastroenterology, 2024
- Evidence-based clinical practice guidelines for cholelithiasis 2021Journal of Gastroenterology, 2023
- Adverse events associated with EUS and EUS-guided proceduresGastrointestinal Endoscopy, 2022
- ASGE guideline on the management of cholangitisGastrointestinal Endoscopy, 2021
- ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasisGastrointestinal Endoscopy, 2019
- Diagnostic accuracy of EUS compared with MRCP in detecting choledocholithiasis: a meta-analysis of diagnostic test accuracy in head-to-head studiesGastrointestinal Endoscopy, 2017
- Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitisJournal of Hepato-Biliary-Pancreatic Sciences, 2017
- Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic diseaseGastrointestinal Endoscopy, 1992